1 of 14

New Global Governance of International Trade and Health

Nakorn Premsri, M.D.

Director of National Vaccine Institute (NVI), Thailand

2 of 14

2

3 of 14

3

4 of 14

4

https://www.bloomberg.com/news/articles/2020-12-09/which-countries-have-reserved-the-most-covid-19-vaccines-u-s-is-32nd-on-list

Over 6,000 M Doses has been advanced purchase

since November 2020, mostly by high Income Countries

5 of 14

  • 53.5% of the world population has received at least one dose of a COVID-19 vaccine.
  • 7.78 billion doses have been administered globally, and 28.26 million are now administered each day.�
  • Only 5.2% of people in low-income countries have received at least one dose.

https://ourworldindata.org/covid-vaccinations

6 of 14

7 of 14

8 of 14

9 of 14

10 of 14

Points of Consideration

  • Benefit of advance supply agreement to accelerate vaccine development but led to over securing of vaccine among high income
  • Compromising the timeliness and equality of vaccine distribution to lower income countries
  • Global platform e.g. COVAX could not adequately perform its task even with the good concept of global vaccine distribution equality.
  • Vaccine Self Reliance VS Vaccine Nationalism
  • Building up the capacity of vaccine manufacturing in developing countries is so challenging but essential.

11 of 14

Thank you

12 of 14

New Global Governance of International Trade and Health

Nakorn Premsri, M.D.

Director of National Vaccine Institute (NVI)

Thailand

13 of 14

Vaccine took months to demonstrate its effectiveness

Vaccination

14 of 14

Vaccination